Regeneron Pharmaceuticals (REGN) EBT Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05% |
| Dec 31, 2025 | -7.64% |
| Sep 30, 2025 | 5.31% |
| Jun 30, 2025 | 16.39% |
| Mar 31, 2025 | -5.17% |
| Dec 31, 2024 | -27.40% |
| Sep 30, 2024 | -6.33% |
| Jun 30, 2024 | -24.30% |
| Mar 31, 2024 | -17.61% |
| Dec 31, 2023 | -2.14% |
| Sep 30, 2023 | 3.62% |
| Jun 30, 2023 | 5.63% |
| Mar 31, 2023 | 8.67% |
| Dec 31, 2022 | 14.18% |
| Sep 30, 2022 | 25.24% |
| Jun 30, 2022 | 62.44% |
| Mar 31, 2022 | 24.78% |
| Dec 31, 2021 | 54.70% |
| Sep 30, 2021 | 41.89% |
| Jun 30, 2021 | 78.84% |
| Mar 31, 2021 | 28.87% |
| Dec 31, 2020 | 30.21% |
| Sep 30, 2020 | 20.85% |
| Jun 30, 2020 | 20.45% |
| Mar 31, 2020 | 15.65% |
| Dec 31, 2019 | 37.60% |
| Sep 30, 2019 | 28.07% |
| Jun 30, 2019 | -8.39% |
| Mar 31, 2019 | 18.26% |
| Dec 31, 2018 | 43.82% |
| Sep 30, 2018 | 17.37% |
| Jun 30, 2018 | 26.00% |
| Mar 31, 2018 | 28.40% |
| Dec 31, 2017 | 169.51% |
| Sep 30, 2017 | 45.98% |
| Jun 30, 2017 | 36.05% |
| Mar 31, 2017 | 33.70% |
| Dec 31, 2016 | 23.53% |
| Sep 30, 2016 | 17.48% |
| Jun 30, 2016 | 25.55% |
| Mar 31, 2016 | 32.53% |
| Dec 31, 2015 | 19.09% |
| Sep 30, 2015 | 27.12% |
| Jun 30, 2015 | 62.28% |
| Mar 31, 2015 | 187.38% |
| Dec 31, 2014 | 16.42% |
| Sep 30, 2014 | 70.33% |
| Jun 30, 2014 | 74.30% |
| Mar 31, 2014 | 83.14% |
| Dec 31, 2013 | 143.35% |
| Sep 30, 2013 | 105.37% |
| Jun 30, 2013 | 98.30% |
| Mar 31, 2013 | 88.02% |
| Dec 31, 2012 | 74.50% |
| Sep 30, 2012 | 475.53% |
| Jun 30, 2012 | 92.54% |